News
Novartis India standalone net profit declines 13.82% in the March 2026 quarter
12-May-2026 | 16:13
Sales rise 7.95% to Rs 90.55 crore
Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.
For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 90.55 | 83.88 | 8 | 354.33 | 356.27 | -1 |
| OPM % | 22.77 | 28.51 | - | 26.56 | 25.66 | - |
| PBDT | 30.56 | 34.42 | -11 | 131.61 | 132.61 | -1 |
| PBT | 30.14 | 33.89 | -11 | 129.66 | 130.42 | -1 |
| NP | 25.25 | 29.30 | -14 | 93.18 | 100.90 | -8 |
Powered by Capital Market - Live News
